Literature DB >> 8093710

Pathomechanisms of photosensitive lupus erythematosus.

D A Norris1.   

Abstract

This review discusses the mechanisms involved in different photosensitive lupus syndromes: acute cutaneous lupus erythematosus, chronic cutaneous (discoid) lupus erythematosus, subacute cutaneous lupus erythematosus, and neonatal lupus erythematosus. It is proposed that there are three principal determinants of photosensitivity in lupus: 1) susceptibility to UVR-induced release of epidermal and dermal cytokines; 2) susceptibility to UVR-induced release or translocation of sequestered antigens in the epidermis or dermis; and 3) different specific immunologic effector mechanisms, activated by cytokines and directed against discrete epidermal targets. Several characteristics of photosensitive lupus are discussed in detail: autoantibody specificities, autoantigen translocation, induction of epidermal intercellular adhesion molecule-a (ICAM-1), vascular activation, cytokine release and T-cell activation, and clinical phototesting. The role of antibodies to the extractable nuclear antigens Ro and La and the relationship to subacute cutaneous lupus erythematosus (SCLE) and neonatal lupus erythematosus is discussed in detail, and a model of SCLE is proposed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8093710     DOI: 10.1111/1523-1747.ep12355599

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  14 in total

1.  Targeted tumor necrosis factor receptor I preligand assembly domain improves skin lesions in MRL/lpr mice.

Authors:  Guo-Min Deng; Lena Liu; George C Tsokos
Journal:  Arthritis Rheum       Date:  2010-08

2.  Neonate with annular plaques of the scalp.

Authors:  Jason Emer; Adam Luber; Mariyah Yazdani; Brian Marciniak; Harleen Sidhu; Robert Phelps
Journal:  J Clin Aesthet Dermatol       Date:  2013-06

3.  Lupus serum IgG induces skin inflammation through the TNFR1 signaling pathway.

Authors:  Guo-Min Deng; Lena Liu; Vasileios C Kyttaris; George C Tsokos
Journal:  J Immunol       Date:  2010-05-14       Impact factor: 5.422

4.  Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus.

Authors:  A I Blakemore; A Cox; A M Gonzalez; J K Maskil; M E Hughes; R M Wilson; J D Ward; G W Duff
Journal:  Hum Genet       Date:  1996-03       Impact factor: 4.132

5.  Susceptibility of T cell receptor-alpha chain knock-out mice to ultraviolet B light and fluorouracil: a novel model for drug-induced cutaneous lupus erythematosus.

Authors:  T Yoshimasu; T Nishide; N Seo; A Hiroi; T Ohtani; K Uede; F Furukawa
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

6.  Anti-Ro52 antibodies, antisynthetase antibodies, and antisynthetase syndrome.

Authors:  Vidya S Limaye; John Cassidy; Grace Scott; Peter J Roberts-Thomson; David Gillis
Journal:  Clin Rheumatol       Date:  2007-10-11       Impact factor: 2.980

7.  The skin immune system: lupus erythematosus as a paradigm.

Authors:  J D Bos
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

8.  Antinuclear autoantibodies and lupus nephritis in transgenic mice expressing interferon gamma in the epidermis.

Authors:  J P Seery; J M Carroll; V Cattell; F M Watt
Journal:  J Exp Med       Date:  1997-11-03       Impact factor: 14.307

Review 9.  Clinical and pathological roles of Ro/SSA autoantibody system.

Authors:  Ryusuke Yoshimi; Atsuhisa Ueda; Keiko Ozato; Yoshiaki Ishigatsubo
Journal:  Clin Dev Immunol       Date:  2012-12-06

Review 10.  Pathophysiology of cutaneous lupus erythematosus.

Authors:  Julie H Lin; Jan P Dutz; Richard D Sontheimer; Victoria P Werth
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 10.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.